CANCLINI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 277
NA - Nord America 92
AS - Asia 56
OC - Oceania 1
Totale 426
Nazione #
DE - Germania 123
IT - Italia 104
US - Stati Uniti d'America 86
CN - Cina 35
GB - Regno Unito 11
SE - Svezia 8
IE - Irlanda 7
IN - India 7
FR - Francia 5
JP - Giappone 4
AL - Albania 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
KR - Corea 3
NL - Olanda 3
RO - Romania 3
TT - Trinidad e Tobago 3
CA - Canada 2
DK - Danimarca 2
HK - Hong Kong 2
AU - Australia 1
BE - Belgio 1
GR - Grecia 1
IL - Israele 1
LB - Libano 1
MX - Messico 1
MY - Malesia 1
TR - Turchia 1
TW - Taiwan 1
Totale 426
Città #
Hanover 115
Milan 23
Mogliano 10
Ashburn 8
Beijing 8
Fairfield 8
Redwood City 8
Southend 8
Rome 7
Chandler 6
Dublin 5
Cagliari 4
Chicago 4
Cincinnati 4
Frankfurt am Main 4
Houston 4
Princeton 4
Alzate Brianza 3
Bengaluru 3
Cambridge 3
Durrës 3
Guangzhou 3
Kent 3
Lanzo d'Intelvi 3
Port of Spain 3
Shenyang 3
Stezzano 3
Zhengzhou 3
Assen 2
Bergamo 2
Brooklyn 2
Chennai 2
Cluj-napoca 2
Copenhagen 2
Galway 2
Genoa 2
Hangzhou 2
Henderson 2
Monza 2
Saronno 2
Settimo Milanese 2
Trieste 2
Upper Marlboro 2
Vancouver 2
Amsterdam 1
Ann Arbor 1
Aubonne 1
Boardman 1
Bolzaneto 1
Boston 1
Bühl 1
Canyon Country 1
Central District 1
Changsha 1
Chesham 1
Chieti 1
Clearwater 1
Cuauhtémoc 1
Des Moines 1
Edinburgh 1
Falls Church 1
Garbagnate Milanese 1
Grafing 1
Istanbul 1
Kuala Lumpur 1
Lake Odessa 1
Liège 1
Los Angeles 1
Nagoya 1
Nanjing 1
New Bedfont 1
New York 1
Padova 1
Parabiago 1
Petah Tikva 1
Rimini 1
Saint Louis 1
San Diego 1
San Gavino Monreale 1
Seattle 1
Seoul 1
Shanghai 1
Stockholm 1
Taipei 1
Taiyuan 1
Umeda 1
Washington 1
Wilmington 1
Woodbridge 1
Wuhan 1
Yongin-si 1
Totale 342
Nome #
Progress and prospects of biological approaches targeting PCSK9 for cholesterol-lowering, from molecular mechanism to clinical efficacy 222
The association of proprotein convertase subtilisin/kexin type 9 to plasma low-density lipoproteins: An evaluation of different methods 165
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 PREFERENTIALLY ASSOCIATES WITH A SPECIFIC LDL SUBFRACTION: A DETAILED CHARACTERIZATION AND STUDY OF THE EFFECTS OF ANTI-PCSK9 MABS TREATMENT 54
Totale 441
Categoria #
all - tutte 1.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 1 14 17 13 12 7 7 8 11 4 9
2021/2022167 4 0 5 0 3 4 6 41 63 31 6 4
2022/2023112 5 5 11 10 18 28 11 4 2 0 14 4
2023/202459 6 3 5 4 7 6 3 7 6 9 3 0
Totale 441